Monitoring DNA–Ligand Interactions in Living Human Cells Using NMR Spectroscopy
Author(s) -
Michaela Krafčíková,
Šimon Džatko,
Coralie Caron,
Anton Granzhan,
Radovan Fiala,
Tomáš Loja,
MariePaule TeuladeFichou,
Tomáš Fessl,
Robert HänselHertsch,
JeanLouis Mergny,
Silvie Foldynová-Trantírková,
Lukáš Trantı́rek
Publication year - 2019
Publication title -
journal of the american chemical society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.115
H-Index - 612
eISSN - 1520-5126
pISSN - 0002-7863
DOI - 10.1021/jacs.9b03031
Subject(s) - chemistry , dna , netropsin , ligand (biochemistry) , biophysics , small molecule , intracellular , nuclear magnetic resonance spectroscopy , base pair , molecule , stereochemistry , combinatorial chemistry , biochemistry , minor groove , receptor , biology , organic chemistry
Studies on DNA-ligand interactions in the cellular environment are problematic due to the lack of suitable biophysical tools. To address this need, we developed an in-cell NMR-based approach for monitoring DNA-ligand interactions inside the nuclei of living human cells. Our method relies on the acquisition of NMR data from cells electroporated with preformed DNA-ligand complexes. The impact of the intracellular environment on the integrity of the complexes is assessed based on in-cell NMR signals from unbound and ligand-bound forms of a given DNA target. This technique was tested on complexes of two model DNA fragments and four ligands, namely, a representative DNA minor-groove binder (netropsin) and ligands binding DNA base-pairing defects (naphthalenophanes). In the latter case, we demonstrate that two of the three in vitro -validated ligands retain their ability to form stable interactions with their model target DNA in cellulo , whereas the third one loses this ability due to off-target interactions with genomic DNA and cellular metabolites. Collectively, our data suggest that direct evaluation of the behavior of drug-like molecules in the intracellular environment provides important insights into the development of DNA-binding ligands with desirable biological activity and minimal side effects resulting from off-target binding.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom